3,3-Difluorohexanoic acid ethyl ester (stabilised over Potassium Carbonate), 250mg

spiro[3.3]heptan-2-ol, 95.0%, 1g

4-Methyl-2-(pyrrolidin-3-yloxy)pyridinehydrochloride, 250mg

Ethyl 5-bromovalerate, 98.0%, 25g

2,2,3,3,4,4,5,5-Octafluoro-1,6-hexanediol, 98.0%, 25g

1-(2-Methyl-benzyl)-piperidin-4-ylamine hydrochloride, 95.0%, 1g

Tungstophosphoric acid hydrate, pa, cryst., 500 g, glass packaging

METHYL 3-(AMINOMETHYL)CYCLOBUTANECARBOXYLATE HCL, 95.0%, 250mg

2-Methyl-1-naphthoic acid, 98.0%, 1g

4-Hydroxynaphthalene-1-carboxylic acid, 98+%, 100mg

4-Methyl-6-nitropyridin-3-ol, 97%, 1g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)pentanoic acid, 97%, 25g

2,4-Dichloro-3,5-dimethylphenol, 96.0%, 500g